Wells Fargo
SGNT

Wells Fargo’s SAGENT PHARMACEUTICALS INC COM STK (DE) SGNT Stock Holding History

Wells Fargo’s Portfolio SGNT Stock Details SGNT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-8,373
Closed -$126K – 6557
2016
Q2 		$126K Sell
8,373
-1,483
-15% -$19.1K ﹤0.01% 4682
2016
Q1 		$120K Buy
9,856
+850
+9% +$11.9K ﹤0.01% 4714
2015
Q4 		$143K Sell
9,006
-809
-8% -$12.7K ﹤0.01% 4679
2015
Q3 		$150K Buy
9,815
+296
+3% +$6.4K ﹤0.01% 4633
2015
Q2 		$231K Buy
9,519
+7,460
+362% +$179K ﹤0.01% 4536
2015
Q1 		$48K Sell
2,059
-3,130
-60% -$82.8K ﹤0.01% 5035
2014
Q4 		$130K Buy
5,189
+2,616
+102% +$76.7K ﹤0.01% 4642
2014
Q3 		$80K Buy
2,573
+1,016
+65% +$27.5K ﹤0.01% 4748
2014
Q2 		$40K Buy
+1,557
New +$34.6K ﹤0.01% 5060
2013
Q4 		– Sell
-1,986
Closed -$41K – 6099
2013
Q3 		$41K Buy
+1,986
New +$44.2K ﹤0.01% 4734

Wells Fargo's SGNT Position: Q3 2016 in Review

Wells Fargo sold out of SAGENT PHARMACEUTICALS INC COM STK (DE) (SGNT) in Q3 2016, closing a stake of 8,373 shares — an estimated $126K sold.

Wells Fargo first reported a position in SGNT in Q3 2013 and held it in 10 quarters. The position peaked at $231K in Q2 2015. 0 funds tracked by Wall St. Rank hold SGNT as of Q3 2016.

  • Wells Fargo reported no remaining SAGENT PHARMACEUTICALS INC COM STK (DE) position as of Q3 2016 after selling out during the quarter.
  • Wells Fargo sold 8,373 SAGENT PHARMACEUTICALS INC COM STK (DE) shares in Q3 2016, an estimated $126K.
  • Wells Fargo first reported a position in SAGENT PHARMACEUTICALS INC COM STK (DE) in Q3 2013 and held it in 10 quarters.
  • Wells Fargo's SAGENT PHARMACEUTICALS INC COM STK (DE) position peaked at $231K in Q2 2015.
  • 0 funds tracked by Wall St. Rank held SAGENT PHARMACEUTICALS INC COM STK (DE) as of Q3 2016.

Based on Wells Fargo's 13F filing for Q3 2016, filed 31 Oct 2016.